• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

340B drug discount program

An image from the Meet Mark ad campaign
Favicon Fierce Healthcare

PhRMA launches ad campaign against '340B medicine mark-ups'

The pharma lobby's seven-figure campaign portrays fictional nonprofit hospital leaders celebrating profits derived from the program's discounts.
Dave Muoio Sep 3, 2025 1:30pm
A rolled up wad of hundred dollar bills with white pills spilling out
Favicon Fierce Healthcare

Hospitals skeptical of 340B rebate pilot's tight comment period

Aug 11, 2025 3:30pm
A rolled up wad of hundred dollar bills with white pills spilling out
Favicon Fierce Healthcare

340B pulled $6.5B in drug rebates from Medicaid in 2024

Jul 15, 2025 4:30pm
Hand scales with money and drugs

J&J ushers in new 340B rebate policy for Stelara, Xarelto

Aug 26, 2024 11:23am
Narasimhan

Novartis CEO outlines post-IRA priorities for pharma industry

Feb 1, 2023 2:52pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings